Cramer: Apple Is Th...
Basic Materials: Energy
American Oil & Gas Inc. (AEZ: AMEX)
$10.20 0.04 | 0.39%
12/17/10 - 04:27 PM ET
TheStreet Ratings Grade for AEZ
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Stong Buy | 1 | 2 | 2 | 3 |
| Moderate Buy | 1 | 2 | 2 | 2 |
| Hold | 3 | 4 | 4 | 3 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 |
| Mean Rec. | 2.83 | 2.56 | 2.25 | 2.00 |
Portfolios with AEZ
- Portfolio NameUser Type
- Userwatch 1
- Useraaswar Portfolio 1
- UserGo Bears $10 Portfolio
- UserWilliam Hine Portfolio 1
- UserNSA Stocks
- Usersbjacobson Portfolio 1
- Usergrob Portfolio 1
- Userchasmatic Portfolio 1
- Useralstocks
- UserMy Everydays
Latest AEZ Headlines from TheStreet
- 'Mad Money Lightning Round': Go for Netflix 07.15.10 | 07:07 pm
- Cramer's 'Mad Money' Recap: Rally on Solid Ground (Update 3) 07.15.10 | 06:07 pm
- Energy Winners: Can Brigham Go Higher? 02.03.10 | 03:02 pm
- Keryx Treatment Gets Faster FDA Review 12.02.09 | 09:12 am
- $5 Energy Stocks
11.19.09 | 06:11 am - What the Future Holds for Natural Gas 09.28.09 | 02:09 pm
- Movers Roundup: AutoZone, Deere 08.18.09 | 05:08 pm
- AEterna Dips Further After Prostate Drug Failure 08.18.09 | 03:08 pm
- Earnings Roundup: Gencor, Harbin Electric 08.11.09 | 02:08 pm
- AEterna Zentaris Cancer Drug Missed Trial Goal 06.08.09 | 06:06 pm
Press Releases for AEZ
- Aeterna Zentaris: Article On Perifosine As Potential Novel Approach To The Treatment Of Mesothelioma Published In Plos One - PR Newswire 05.31.12 | 07:05 am
- Aeterna Zentaris Receives Notification From NASDAQ Relating To Minimum Bid Price - PR Newswire 05.16.12 | 04:05 pm
- Aeterna Zentaris Presents Preclinical Data For Its Anti-Cancer PI3K/ Erk 1/2 Inhibitor, AEZS-136, At AACR Meeting - PR Newswire 04.03.12 | 07:04 am
- Aeterna Zentaris Announces Top-Line Data From The Perifosine Phase 3 Trial In Refractory Advanced Colorectal Cancer - PR Newswire 04.02.12 | 07:04 am
- Aeterna Zentaris To Present At Needham Healthcare Conference In New York - PR Newswire 03.29.12 | 07:03 am
- Aeterna Zentaris To Announce Fourth Quarter And Full Year 2011 Financial And Operating Results On March 27, 2012 - PR Newswire 03.20.12 | 07:03 am
- Michael E. DeBakey VA Medical Center Initiates Phase 2A Trial In Cancer Cachexia With Aeterna Zentaris' Ghrelin Agonist, AEZS-130 - PR Newswire 03.08.12 | 07:03 am
- Aeterna Zentaris To Present At Cowen And Company 32nd Annual Health Care Conference In Boston - PR Newswire 02.29.12 | 07:02 am
- Aeterna Zentaris To Present At BIO CEO Investor And RBC Capital Markets Global Healthcare Conferences In New York - PR Newswire 02.07.12 | 07:02 am
- Aeterna Zentaris Reports Updated Phase 1 Trial Results For AEZS-108 In Castration- And Taxane-Resistant Prostate Cancer At ASCO GCS Meeting - PR Newswire 02.03.12 | 07:02 am
Partner Headlines for AEZ
- UPDATE 1-Aeterna loss smaller than expected due to royalties - Reuters 03.22.11 | 11:03 am
- New Bakken Acres in Hess Pie - Analyst Blog - Zacks 12.30.10 | 11:12 am
- UPDATE 1-Aeterna Zentaris loss narrows on lower R&D costs - Reuters 08.12.10 | 07:08 am
- UPDATE 2-Aeterna/Keryx soar on perifosine orphan drug status - Reuters 07.14.10 | 02:07 pm
- UPDATE 1-Aeterna to advance cancer trial after European nod - Reuters 05.17.10 | 07:05 am
- UPDATE 1-Aeterna quarterly loss narrows on lower costs - Reuters 05.13.10 | 07:05 am
- UPDATE 1-Aeterna moves ahead on bladder cancer drug trial - Reuters 05.12.10 | 08:05 am
- UPDATE 1-Aeterna cancer treatment gets orphan-drug status - Reuters 05.06.10 | 08:05 am
- UPDATE 2-Aeterna cancer drug gets US fast track designation - Reuters 04.05.10 | 10:04 am
- UPDATE 3-Aeterna returns to profit, sees lower license fees - Reuters 03.24.10 | 12:03 pm
